AVACEN 100

November 1, 2017November 1, 2017

Avacen Medical Wins Innovation Award for Fibromyalgia Pain Control Device

News

Avacen Medical has received an innovation award for a dry heat device it invented to treat the pain that is widespread in fibromyalgia. The global consulting firm Frost & Sullivan gave Avacen its European New ... Read more

October 4, 2017October 4, 2017

Health Canada Approves AVACEN 100 to Treat Pain in Fibromyalgia Patients

Fibromyalgia, News

Avacen Medical recently announced that its Avacen 100 Class II medical device, previously licensed for treating joint pain associated with arthritis, is now licensed by Health Canada to treat generalized ... Read more

August 14, 2017August 14, 2017

Avacen Receives CE Mark in EU for Device Designed to Treat Fibromyalgia Pain

News

Avacen Medical recently announced that its product Avacen 100, an over-the-counter (OTC) medical device designed to treat widespread fibromyalgia pain and increase blood circulation, has received CE Marking. The CE Mark means the product meets ... Read more

June 16, 2017June 16, 2017

Avacen and CellMark Team Up to Market Non-Drug Treatment Device for Fibromyalgia Pain

News

San Diego-based biotech company Avacen Medical and CellMark Medical of Gothenburg, Sweden, have formed a strategic partnership to leverage CellMark’s global network across 120 markets to boost sales and marketing of the Avacen-100 Class-II ... Read more

May 31, 2017May 31, 2017

Health Canada Approves Avacen’s Non-Drug Treatment Device for Fibromyalgia Pain

News

Avacen Medical says its Avacen 100 Class-II medical pain treatment product has received a medical device license from Health Canada to treat fibromyalgia. The San Diego-based biotech firm’s marquee product uses a non-invasive technique ... Read more

January 4, 2017January 4, 2017

Avacen 100 Device for Relieving Fibromyalgia Pain Earns EU Marketing Approval

News

Avacen Medical has received approval to market its Avacen 100 device, which decreases pain associated with fibromyalgia (FM), in the European Union. Avacen 100 is an FDA-approved, drug-free, non-invasive ... Read more

October 19, 2016October 19, 2016

Avacen Medical Supports Simplifying NIH Clinical Trial Reports

News

Avacen Medical announced its strong support for a new initiative by the National Institutes of Health (NIH) to expand and enforce its requirement for clinical trial results to be published on ClinicalTrials.gov. The ... Read more

December 21, 2015December 21, 2015

Fibromyalgia Heat Exchange Therapy Shows Promise

News

Avacen Medical announced promising results from a clinical trial investigating the AVACEN Thermal Exchange System for fibromyalgia treatment, with findings of reduced pain across a widespread index of measures in study participants. The ... Read more

September 14, 2015September 14, 2015

Drug-Free, Rapid Whole-Body Muscle Relaxation Solution Debuts at Las Vegas “PAINWeek”

News

San Diego, California based AVACEN Medical introduced its FDA cleared noninvasive AVACEN 100 muscle relaxation medical device at the PAINWeek 2015 conference that ran from September 8 to 12 at ... Read more